Atara Biotherapeutics Inc
F:AT2
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Atara Biotherapeutics Inc
F:AT2
|
US |
|
H
|
Haier Smart Home Co Ltd
DUS:690D
|
CN |
|
A
|
Asahi Kasei Corp
F:ASAA
|
JP |
|
E
|
EchoStar Corp
F:E20
|
US |
|
W
|
Walmart Inc
XMUN:WMT
|
US |
|
Broadcom Inc
SIX:AVGO
|
US |
|
F
|
Finnair Oyj
SWB:FAI
|
FI |
|
H
|
Hasbro Inc
DUS:HAS
|
US |
|
Dynamic Brands Inc
OTC:ASCC
|
US |
|
O
|
ON Semiconductor Corp
F:XS4
|
US |
|
BAE Systems PLC
LSE:BA
|
UK |
|
H
|
Home Depot Inc
XMUN:HDI
|
US |
|
B
|
British American Tobacco PLC
F:BMTA
|
UK |
|
F
|
Five Below Inc
F:6F1
|
US |
|
C
|
Coca-Cola Co
XMUN:CCC3
|
US |
|
CGI Inc
F:CJ5A
|
CA |
|
A
|
Akamai Technologies Inc
F:AK3
|
US |
|
S
|
Siemens AG
DUS:SIE
|
DE |
|
IMCD NV
AEX:IMCD
|
NL |
|
O
|
Origin Bancorp Inc
F:36Z
|
US |
|
F
|
Franklin Resources Inc
XMUN:FRK
|
US |
|
Draegerwerk AG & Co KGaA
F:DRW8
|
DE |
|
G
|
GEA Group AG
F:G1A
|
DE |
|
O
|
OneSpan Inc
F:VDY
|
US |
Bankruptcy Probability
Atara Biotherapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Atara Biotherapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Atara Biotherapeutics Inc
NASDAQ:ATRA
|
68.2m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
356.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
179.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
163B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
109.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
75.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
41.5B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
57.8B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Atara Biotherapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Atara Biotherapeutics Inc has total debt of 32.7m USD. This includes both short-term (0 USD) and long-term (32.7m USD) debt.
You can find a full breakdown on its Balance Sheet.
